3rd Annual Precision Medicine Congress
Visit Q2 Solutions Booth # 15, meet our meet our Precision Medicine and Companion Diagnostic Experts and attend our Podium Presentation.
About This Event
Sign up to receive our podium presentation slides from our expert on Companion Diagnostic development post-event.
Attend our podium presentation on Tuesday, September 13, 2016 | 12:35-13:05
Topic: Biomarker and Companion Diagnostics Development to Deliver Precision Medicine
Presentation Title and Abstract:
Best practices in partnering with your laboratory for successful Companion Diagnostic development
- Top partnership models to optimize your CDx clinical trials
- Lessons learned for CDx projects: a lab perspective
- Is the LDT route still the best option?
Chief Scientific Officer
Patrice Hugo, Ph.D. is chief scientific officer of Q2 Solutions, a Quintiles Quest Joint Venture. Dr. Hugo leads the organization’s global scientific strategy and implementation, developing and accelerating strategies to help improve human health through innovation that transforms science and data into actionable medical insights.
Dr. Hugo brings more than 25 years of senior scientific leadership experience with extensive management expertise in laboratory operations applied to diagnostics, therapeutic targets and clinical trials. Most recently, Dr. Hugo was Associate Vice President and Chief Scientist at Laboratory Corporation of America (LabCorp). He has held several other senior leadership positions at companies including LabCorp, Clearstone Central Laboratories, Caprion and PROCREA BioSciences. A noted industry expert, Dr. Hugo has more than 75 scientific publications in internationally renowned journals. He also is active in a number of industry organizations, including his role on the Board of Directors for the non-for-profit Personalized Medicine Partnership for Cancer in Quebec, Warnex offering analytical and bioanalytical services and his role as a Steering Committee Member for the Biomarker Factory.
Dr. Hugo obtained his Ph.D. at McGill University and completed five years of post- doctoral fellowship at the Walter Elisa Hall Institute in Australia, and Howard Hughes Medical Institute in Denver, Colorado.